145 related articles for article (PubMed ID: 37462223)
41. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
[TBL] [Abstract][Full Text] [Related]
42. Effects of L-carnitine and ginkgo biloba extract (EG b 761) in experimental bleomycin-induced lung fibrosis.
Daba MH; Abdel-Aziz AA; Moustafa AM; Al-Majed AA; Al-Shabanah OA; El-Kashef HA
Pharmacol Res; 2002 Jun; 45(6):461-7. PubMed ID: 12162946
[TBL] [Abstract][Full Text] [Related]
43. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
44. Aprepitant exerts anti-fibrotic effect via inhibition of TGF-β/Smad3 pathway in bleomycin-induced pulmonary fibrosis in rats.
Mohamed MZ; Abed El Baky MF; Ali ME; Hafez HM
Environ Toxicol Pharmacol; 2022 Oct; 95():103940. PubMed ID: 35931359
[TBL] [Abstract][Full Text] [Related]
45. Atractylenolide III attenuates bleomycin-induced experimental pulmonary fibrosis and oxidative stress in rat model via Nrf2/NQO1/HO-1 pathway activation.
Huai B; Ding J
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):436-444. PubMed ID: 32762376
[TBL] [Abstract][Full Text] [Related]
46. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
47. Astragalus injection attenuates bleomycin-induced pulmonary fibrosis via down-regulating Jagged1/Notch1 in lungs.
Zhou Y; Liao S; Zhang Z; Wang B; Wan L
J Pharm Pharmacol; 2016 Mar; 68(3):389-96. PubMed ID: 26817817
[TBL] [Abstract][Full Text] [Related]
48. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
[TBL] [Abstract][Full Text] [Related]
49. Effects of erdosteine on bleomycin-induced lung fibrosis in rats.
Boyaci H; Maral H; Turan G; Başyiğit I; Dillioğlugil MO; Yildiz F; Tugay M; Pala A; Erçin C
Mol Cell Biochem; 2006 Jan; 281(1-2):129-37. PubMed ID: 16328965
[TBL] [Abstract][Full Text] [Related]
50. Daidzein exhibits anti-fibrotic effect by reducing the expressions of Proteinase activated receptor 2 and TGFβ1/smad mediated inflammation and apoptosis in Bleomycin-induced experimental pulmonary fibrosis.
Soumyakrishnan S; Divya T; Kalayarasan S; Sriram N; Sudhandiran G
Biochimie; 2014 Aug; 103():23-36. PubMed ID: 24769130
[TBL] [Abstract][Full Text] [Related]
51. Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways.
Xiong Y; Cui X; Zhou Y; Chai G; Jiang X; Ge G; Wang Y; Sun H; Che H; Nie Y; Zhao P
Int Immunopharmacol; 2021 Sep; 98():107780. PubMed ID: 34118645
[TBL] [Abstract][Full Text] [Related]
52. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
[TBL] [Abstract][Full Text] [Related]
53. Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats.
Chen L; Wang T; Wang X; Sun BB; Li JQ; Liu DS; Zhang SF; Liu L; Xu D; Chen YJ; Wen FQ
Respir Res; 2009 Jun; 10(1):55. PubMed ID: 19552800
[TBL] [Abstract][Full Text] [Related]
54. Trigonelline mitigates bleomycin-induced pulmonary inflammation and fibrosis: Insight into NLRP3 inflammasome and SPHK1/S1P/Hippo signaling modulation.
Zeyada MS; Eraky SM; El-Shishtawy MM
Life Sci; 2024 Jan; 336():122272. PubMed ID: 37981228
[TBL] [Abstract][Full Text] [Related]
55. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
56. Protective effect of rutin against bleomycin induced lung fibrosis: Involvement of TGF-β1/α-SMA/Col I and III pathway.
Bai L; Li A; Gong C; Ning X; Wang Z
Biofactors; 2020 Jul; 46(4):637-644. PubMed ID: 32233122
[TBL] [Abstract][Full Text] [Related]
57. Sinapic acid ameliorates bleomycin-induced lung fibrosis in rats.
Raish M; Ahmad A; Ahmad Ansari M; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
Biomed Pharmacother; 2018 Dec; 108():224-231. PubMed ID: 30219680
[TBL] [Abstract][Full Text] [Related]
58. Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats.
Punithavathi D; Venkatesan N; Babu M
Br J Pharmacol; 2000 Sep; 131(2):169-72. PubMed ID: 10991907
[TBL] [Abstract][Full Text] [Related]
59. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
Zhang D; Liu B; Cao B; Wei F; Yu X; Li GF; Chen H; Wei LQ; Wang PL
Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015
[TBL] [Abstract][Full Text] [Related]
60. Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9.
Zhao L; Mu B; Zhou R; Cheng Y; Huang C
Int J Rheum Dis; 2019 Apr; 22(4):686-694. PubMed ID: 30666825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
